This website discusses uses of aspirin not approved by the Food and Drug Administration.

While the evidence for aspirin use in chemoprevention of cancer to date is promising, additional research is needed before aspirin can be recommended for regular use in groups at elevated risk. As the makers of Bayer® Aspirin, we have provided support for numerous studies to evaluate aspirin's potential to address unmet health needs. Bayer is committed to working with the scientific community to maximize the utility of aspirin as scientific support evolves.

Consumers are advised to consult their physicians regarding their risk factors for cancer and appropriate prevention strategies including adequate fiber intake, smoking cessation, etc. The determination of who is an appropriate candidate for aspirin therapy and what, if any, lifestyle or other disease prevention measures are appropriate, should be made with a health professional.